Webinar: Untangling the Vaccine Mandate: Practical Steps for Contractors to Navigate Executive Order 14042
- Please join us on October 14, 2021, as we discuss the latest developments on Biden's Executive Order 14042 in our upcoming webinar, "Untangling the Vaccine Mandate: Practical Steps for Contractors to Navigate Executive Order 14042," from 1:00 p.m. - 2:30 p.m. EDT. On September 24, 2021, the... ›
What To Do Now: Task Force Seeks Broad Coverage and Stringent COVID-19 Protocols for Contractors
By: Andrew R. Turnbull
On September 24, 2021, the Safer Federal Workforce Task Force (the “Task Force”) issued guidance (the “Guidance”) on President Biden’s Executive Order 14042 (the “Order”). Although the Guidance recognizes that the Order is limited to only certain types of contracts, the Task Force strongly encourages... ›New Guidance on COVID-19 Protocols for Contractor Employees at Federal Facilities
By: Andrew R. Turnbull
On September 17, 2021, the Safer Federal Workforce Task Force (the “Task Force”) issued updated guidance (the “Guidance”) to federal agencies about COVID-19 safety protocols for employees of federal contractors and federal employees. While the Guidance is mostly targeted at COVID-19 vaccine and testing... ›President Biden Will Require Certain Federal Contractors and Businesses to Mandate COVID-19 Vaccines or Regular Testing for Employees
By: Andrew R. Turnbull
On September 9, 2021, President Biden issued a six-pronged Path Out of the Pandemic (the “Plan”) and Executive Order on Ensuring Adequate COVID Safety Protocols for Federal Contractors (“EO”) that will require certain federal contractors and businesses with 100 or more employees to have... ›A Return to Normalcy? Check Your Local Rules – An Update on Mask Litigation and Guidelines
By: Lloyd Aubry and Michael G. Ahern
Nine months ago, we discussed several issues that had been raised by COVID-19 face mask-related litigation. [1] Soon after, COVID-19 infection rates spiked to unprecedented levels. But with the emergency use authorization of three COVID-19 vaccines in the United States, the state of the... ›Illinois Ushers In New Restrictions on Non-competes and Non-solicits
By: Eric Akira Tate and Andrew R. Turnbull
On May 31, 2021, the Illinois General Assembly passed amendments to the Illinois Freedom to Work Act (the “Amendments”) that aim to impose significant new restrictions on employee non-compete and non-solicit agreements in Illinois. Illinois Governor J.B. Pritzker is expected to sign the Amendments... ›New Cal/OSHA COVID-19 Standards Relax Workplace Restrictions
By: Andrew R. Turnbull
On June 17, 2021, Cal/OSHA adopted revised COVID-19 Prevention Emergency Temporary Standards, relaxing many of the previous COVID-19 requirements for employers in light of the growing number of vaccinated individuals in the state. The new standards go into effect immediately and apply to most... ›California Expands Coverage for COVID-19 Supplemental Paid Sick Leave
By: Andrew R. Turnbull
On March 19, 2021, California Governor Gavin Newson signed Senate Bill 95, requiring California employers with more than 25 employees to provide their employees with Supplemental Paid Sick Leave (SPSL) for various COVID-related absences. Coverage under this new legislation is far more expansive than last... ›Podcast: COVID-19 Vaccines in the Workplace
By: Michael Ward Ph.D.
In this fifth episode of our podcast series on COVID-19, Michael Ward , MoFo partner and global head of the firm’s Life Sciences Group and Patent Group, discusses with Janie Schulman, employment and labor partner in our Los Angeles office as well as co-chair of... ›- - Discrimination, EEOC, Americans with Disabilities Act (ADA), Coronavirus (COVID-19), Paid Sick Leave
What Employers Need to Know: EEOC Serves Up COVID-19 Vaccine Guidance
In the wake of the U.S. Food and Drug Administration’s first grant of Emergency Use Authorization (EUA) for a COVID-19 vaccine, the Equal Employment Opportunity Commission (EEOC) updated its pandemic guidance to address the legal issues surrounding the intersection of the COVID-19 vaccine and... ›